ATE143413T1 - Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns - Google Patents

Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns

Info

Publication number
ATE143413T1
ATE143413T1 AT88403229T AT88403229T ATE143413T1 AT E143413 T1 ATE143413 T1 AT E143413T1 AT 88403229 T AT88403229 T AT 88403229T AT 88403229 T AT88403229 T AT 88403229T AT E143413 T1 ATE143413 T1 AT E143413T1
Authority
AT
Austria
Prior art keywords
dna
hap
retinoic acid
hepatoma
probe
Prior art date
Application number
AT88403229T
Other languages
English (en)
Inventor
Pierre Tiollais
Anne Dejean
De The Hugues Blaudin
Agnes Marchio
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/134,130 external-priority patent/US5223606A/en
Priority claimed from US07/209,009 external-priority patent/US5149781A/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE143413T1 publication Critical patent/ATE143413T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88403229T 1987-12-16 1988-12-16 Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns ATE143413T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13368787A 1987-12-16 1987-12-16
US07/134,130 US5223606A (en) 1987-12-16 1987-12-17 Steroid/thyroid hormone receptor-related protein inappropriately expressed in human hepatocellular carcinoma
US07/209,009 US5149781A (en) 1987-12-16 1988-06-20 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
US27813688A 1988-11-30 1988-11-30

Publications (1)

Publication Number Publication Date
ATE143413T1 true ATE143413T1 (de) 1996-10-15

Family

ID=27495052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88403229T ATE143413T1 (de) 1987-12-16 1988-12-16 Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns

Country Status (8)

Country Link
US (3) US6531585B1 (de)
EP (1) EP0321362B1 (de)
AT (1) ATE143413T1 (de)
CA (1) CA1320161C (de)
DE (1) DE3855577T2 (de)
ES (1) ES2095207T3 (de)
GR (1) GR3021954T3 (de)
WO (1) WO1989005854A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012687A1 (en) * 1988-06-16 1989-12-28 La Jolla Cancer Research Foundation Retinoic acid receptor
US6335159B1 (en) 1988-06-16 2002-01-01 The Burnham Institute Retinoic acid receptor ε(rarε)
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
EP0411323A3 (en) * 1989-06-30 1991-08-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Human and mouse retinoic acid receptors and genes encoding for them
FR2658204A1 (fr) * 1990-02-12 1991-08-16 Inst Nat Sante Rech Med Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
US5922596A (en) * 1990-12-10 1999-07-13 Bristol-Myers Squibb Co. Promoter of the retinoic acid receptor gene for directing gene expression
EP1290217A2 (de) * 2000-02-04 2003-03-12 Aeomica, Inc. Methoden und apparat zur voraussage, bestätigung und darstellung funktionaler information, abgeleitet von genomischen sequenzen
US9585857B2 (en) 2013-01-18 2017-03-07 Cornell University Methods of treating diseases associated with high-fat diet and vitamin A deficiency using retinoic acid receptor agonists
JP7727628B2 (ja) 2019-12-03 2025-08-21 アラマー バイオサイエンシーズ， インク． 核酸結合免疫サンドイッチアッセイ（ｎｕｌｉｓａ）
US12704508B2 (en) 2021-06-02 2026-08-11 Alamar Biosciences, Inc. Nucleic acid linked immune-sandwich assay (NULISA)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034114A (en) * 1976-09-15 1977-07-05 Yu Ruey J Treatment of skin keratoses with retinal
US4323581A (en) * 1978-07-31 1982-04-06 Johnson & Johnson Method of treating carcinogenesis
US4310546A (en) * 1978-07-31 1982-01-12 Johnson & Johnson Novel retinoids and their use in preventing carcinogenesis
US4385175A (en) * 1982-03-22 1983-05-24 Bristol-Myers Company Esters of retinoic acid and azetidinone derivatives
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition
US5571692A (en) * 1987-12-02 1996-11-05 The Salk Institute For Biological Studies Retinoic acid receptor α, vectors and cells comprising the same DNA encoding
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method

Also Published As

Publication number Publication date
US20060189798A1 (en) 2006-08-24
CA1320161C (en) 1993-07-13
EP0321362B1 (de) 1996-09-25
DE3855577T2 (de) 1997-04-17
US20030153740A1 (en) 2003-08-14
GR3021954T3 (en) 1997-03-31
ES2095207T3 (es) 1997-02-16
US6531585B1 (en) 2003-03-11
DE3855577D1 (de) 1996-10-31
WO1989005854A1 (en) 1989-06-29
EP0321362A1 (de) 1989-06-21
US7622266B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
Tanaka et al. A novel sequence found at the 3′-terminus of hepatitis C virus genome
Ray et al. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity
Nabel et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Yuh et al. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus
Mizushima-Sugano et al. Cell-type-specific transcription of an immunoglobulin kappa light chain gene in vitro.
de Villiers et al. A small segment of polyoma virus DNA enhances the expression of a cloned β-globin gene over a distance of 1400 base pairs
Zhang et al. Effects of hepatitis B virus X protein on the development of liver cancer
Pancholi et al. DNA prime/canarypox boost—based immunotherapy of chronic hepatitis B virus infection in a chimpanzee
Pruijn et al. Promoter and enhancer elements containing a conserved sequence motif are recognized by nuclear factor III, a protein stimulating adenovirus DNA replication.
Yamamoto et al. Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection
Shaul et al. Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences.
Jun-Bin et al. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction
DE3855577D1 (de) Retinoesäurerezeptor und Derivate davon, beide Substanzen codierende DNS und die Verwendung der Proteine und der DNS
WO2001039797A3 (en) Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
IL142989A0 (en) Nucleotide and protein sequences of nogo genes and methods based thereon
Lo et al. Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome
DK0702085T3 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
Kadereit et al. Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins.
Gerner et al. Hepatitis B virus core promoter mutations in children with multiple anti‐HBe/HBeAg reactivations result in enhanced promoter activity
CN108018267B (zh) 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用
Patton et al. Cell-free synthesis and assembly of vesicular stomatitis virus nucleocapsids
Fukai et al. Characterization of a specific region in the hepatitis B virus enhancer I for the efficient expression of X gene in the hepatic cell
Ward et al. Neuron-specific regulation of major histocompatibility complex class I, interferon-β, and anti-viral state genes
Wertz Replication of vesicular stomatitis virus defective interfering particle RNA in vitro: transition from synthesis of defective interfering leader RNA to synthesis of full-length defective interfering RNA
Laskus et al. Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time